[1]BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CACancer J Clin, 2018, 68 (6) :394-424.
|
[2]FU J, WANG H.Precision diagnosis and treatment of liver cancer in China[J].Cancer Lett, 2018, 412 (1) :283-288.
|
[3]ZENG H, CHEN W, ZHENG R, et al.Changing cancer survival in China during 2003-15:A pooled analysis of 17 population-based cancer registries[J].Lancet Glob Health, 2018, 6 (5) :e555-e567.
|
[4]ATTWA MH, El-ETREBY SA.Guide for diagnosis and treatment of hepatocellular carcinoma[J].World J Hepatol, 2015, 7 (12) :1632-1651.
|
[5]MARRERO JA, FENG Z, WANG Y, et al.Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alphafetoprotein in early hepatocellular carcinoma[J].Gastroenterology, 2009, 137 (1) :110-118.
|
[6]GLINKA A, WU W, DELIUS H, et al.Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction[J].Nature, 1998, 391 (6665) :357-362.
|
[7]SHEN Q, FAN J, YANG XR, et al.Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma:Alarge-scale, multicentre study[J].Lancet Oncol, 2012, 13 (8) :817-826.
|
[8]KIMURA H, FUMOTO K, SHOJIMA K, et al.CKAP4 is a Dickkopf1 receptor and is involved in tumor progression[J].J Clin Invest, 2016, 126 (7) :2689-2705.
|
[9]BRUIX J, SHERMAN M.Management of hepatocellular carcinoma[J].Hepatology, 2005, 42 (5) :1208-1236.
|
[10]LLOVET JM, DI BISCEGLIE AM, BRUIX J, et al.Design and endpoints of clinical trials in hepatocellular carcinoma[J].JNatl Cancer Inst, 2008, 100 (10) :698-711.
|
[11]Experts in combined team of the Major Special Project of Ministry of Science and Technology supported by China’s“Twelfth Five-Year Plan”.Management of clinical diagnosis, evaluation, and antiviral therapy for HBV-related cirrhosis[J].J Clin Hepatol, 2014, 30 (2) :99-108. (in Chinese) 科技部十二五重大专项联合课题组专家.乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理[J].临床肝胆病杂志, 2014, 30 (2) :99-108.
|
[12]Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese, Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
[13]SHEN Q, YANG XR, TAN Y, et al.High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomy[J].Hepat Oncol, 2015, 2 (3) :231-244.
|
[14]XIE RZ, CHEN SH.Diagnostic value of combined serum AFP, TK1 and DKK1 levels in primary liver cancer[J].Int J Lab Med, 2018, 39 (8) :939-941, 946. (in Chinese) 谢荣章, 陈树华.联合血清AFP、TK1及DKK1水平检测对原发性肝癌诊断价值研究[J].国际检验医学杂志, 2018, 39 (8) :939-941, 946.
|
[15]BLANK S, WANG Q, FIEL MI, et al.Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma:Normal is not the new normal[J].Ann Surg Oncol, 2014, 21 (3) :986-994.
|
[16]KIM SU, PARK JH, KIM HS, et al.Serum dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma[J].Yonsei Med J, 2015, 56 (5) :1296-1306.
|
[17]LI SX, LIU LJ, DONG LW, et al.CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EG-FR signaling[J].Tumour Biol, 2014, 35 (8) :7999-8005.
|
[18]LI SX, TANG GS, ZHOU DX, et al.Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma[J].Cancer, 2014, 120 (10) :1520-1531.
|